Searchable abstracts of presentations at key conferences in endocrinology

ea0016s18.4 | Doping – an issue for clinical endocrinologists | ECE2008

Distinction between endogenous and exogenous erythropoietin (EPO)

Segura Jordi

Sports authorities prohibited the use of EPO in 1988 and at present any analogue or mimetic is also included in the list of prohibited substances from the World Anti-Doping Agency (WADA). The presentation will summarize the main analytical strategies developed to identify the presence of recombinant erythropoietin (EPO) administered as a doping agent.Indirect evidence is based on the analysis of blood parameters (haemoglobin, haematocrit, reticulocytes, ...

ea0014s2.2 | Hormones and the brain | ECE2007

Neuroprotective actions of estrogens in the central nervous system

Garcia-Segura Luis , Azcoitia Iñigo

Sex hormones act both as endocrine signals as well as local paracrine or autocrine factors in the nervous system. In addition to target to classical endocrine and reproductive brain areas, sex hormones and its metabolites affect learning and cognition and regulate the development and plasticity of brain regions that are not directly related to reproduction. Estrogen and progesterone exert neuroprotective effects in the central nervous system and may affect the onset and progre...

ea0037gp.14.07 | Diabetes and obesity – Clinical diabetes | ECE2015

Degree of control of type 2 diabetes in Spain according to individualised glycaemic targets

Minambres Inka , Mediavilla Jose Javier , Gonzalez-Segura Diego , Perez Antonio

Our objective was to estimate the distribution of Spanish diabetic patients attending to individualized glycaemic targets recommended by the ADA/EASD consensus with and without considering hypoglycaemia risk. We conducted a cross-sectional study in a Spanish primary care setting between 2011 and 2012. A total of 5382 type 2 diabetic subjects under antihyperglycaemic treatment for at least 3 months prior to inclusion completed a study visit in which clinical data including age,...

ea0049gp156 | Neuroendocrinology & Growth Hormones | ECE2017

Liraglutide treatment prevented the increased expression of proinflammatory cytokines in the hippocampus of male pups in a perinatal stress model of food restriction

Diz-Chaves Yolanda , Toba Laura , Fandino Juan , Gonzalez-Matias Lucas , Garcia-Segura Luis Miguel , Mallo Federico

Adverse events during gestation in rodents, results in an enhancement of immune function, including elevated levels of inflammatory cytokines in the brain. Liraglutide is a GLP-1 receptor agonists known to exert neuroprotective effects in brain. The aim of this study was to elucidate if liraglutide given to food restricted (FR) pregnant rats may prevent the deleterious effects of FR in the hippocampal inflammatory status of male and female pups at 21 days of age (D21). 20 Spra...

ea0007s32 | Joint BES and EFES symposium: Neuroactive steroids: implications for disease and healthy ageing | BES2004

Glial cells as mediators of the neuroprotective effects of oestrogen in the central nervous system

Garcia-Segura L , Veiga S , Mendez P , Garcia-Ovejero D , DonCarlos L , Azcoitia I

Endogenous as well as exogenous androgens and oestrogen have neuroprotective properties. Oestrogen is formed locally in neural tissue from precursor androgens. In the brain, the expression of aromatase, the enzyme that catalyses the conversion of androgens to oestrogen, is restricted, under normal circumstances, to specific neuronal populations involved in neuroendocrine control and in the modulation of reproductive or sexually dimorphic behaviours. However, the expression of ...

ea0090p393 | Endocrine-related Cancer | ECE2023

Hypogonadism as a first manifestation of Poems Syndrome

Serisuelo Meneu Esther , Pla Peris Begona , Roxana Padilla Segura Mayet , Abellan Galiana Pablo , Franch Salvador Sara , Angel Merchante Alfaro Agustin

Introduction: Poems Syndrome is a rare multisystem disorder characterized by polyneuropathy, organomegaly, endocrinopathy, monoclonal plasma-proliferative disorder and skin changes, among other features. Literature describes endocrine abnormalities at least in 93% of patients with Poems Syndrome during the diagnosis as well as during the follow-up. The most common deficiencies ranked by their frequency are hypogonadism, hyperprolactinemia, hypothyroidism, abnormal glucose meta...

ea0037ep1276 | Clinical Cases–Thyroid/Other | ECE2015

Case report: superior vena cava syndrome secondary to intrathoracic goitre

Garcia-Bray Bruno Francisco , Felipe-Perez Nieves Cruz , Darias-Garzon Ricardo , Rivero-Melian Benigno , Llorente-Gomez de Segura Ignacio

Introduction: We introduce a case involving the appearance of superior vena cava syndrome secondary to intrathoracic goitre. We discuss the diagnosis, prognosis and treatment applied to this pathology.Case report: A 67-year-old woman who presents respiratory distress, cough, and weight loss. After physical examination and a chest radiography showing a mass that occupied the upper and middle right lung lobes, a neoplasm is suspected and at first, palliati...

ea0032p382 | Diabetes | ECE2013

Assessment of pre-pregnancy BMI in patients with gestational diabetes

Segura-Galindo Amparo , Fernandez-Alonso Ana Maria , Moreno-Ruiz Inmaculada , Sebastian-Ibanez Virginia , Canizo-Gomez Francisco Javier del

Objective: Relationship between pre-pregnancy BMI (PPBMI) in gestational diabetic (GD) patients, and age, country of origin, family history of type 2 diabetes mellitus (T2DM), GD history, and BMI after pregnancy.Methods: Transversal, descriptive study of 259 consecutive pregnant with confirmed DG. Analysis were based on Fisher’s exact test and Student’s t-test. A P<0.05 was significant (SPSS 19.0).Re...

ea0029p639 | Diabetes | ICEECE2012

Serum high sensitivity c-reactive protein as predictor of metabolic syndrome and its relationship with albuminuria in type 2 diabetes mellitus

del Canizo-Gomez F , Moreno-Ruiz I , Silveira-Rodriguez B , De Gorospe C , Gonzalez-Losada T , Segura-Galindo A

The high sensitivity C-reactive protein (hs-CRP), mediator of atherosclerotic disease, is known to be a sensitive predictor of coronary heart disease in type 2 diabetes mellitus (T2DM).Aims: To evaluate the relationship of hs-CRP levels to metabolic syndrome (MS) and albuminuria in T2DM.Methods: Four hundred and eighty-eight T2DM subjects were recruited. Patients with hs-CRP ≥10 mg/l, creatinine ≥1.4 mg/dl, chronic infl...